Law Firms Mallinckrodt and Mallinckrodt FollowJuly 26 (Reuters) - Drugmaker Mallinckrodt (MNK.A) is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to opioids, the Wall Street Journal reported on Wednesday.
Mallinckrodt, which is one of the largest manufacturers for opiods, had filed for bankruptcy protection nearly three years ago.
It reached a $1.7 billion nationwide settlement as part of its bankruptcy reorganization plan and emerged from Chapter 11 last year.
The company in June said it was considering a second bankruptcy filing and other options after its lenders raised concerns over the $200 million payment related to opioid-related litigation.
Reporting by Sriparna Roy in Bengaluru; Editing by Devika SyamnathOur Standards: The Thomson Reuters Trust Principles.
Persons:
Mallinckrodt, Sriparna Roy, Devika
Organizations:
Wall Street, Silver Point, Thomson
Locations:
Greenwich, Bengaluru